GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $379,000 | +0.8% | 8,703 | +1.0% | 0.06% | +16.0% |
| Q1 2022 | $376,000 | -8.7% | 8,618 | -7.7% | 0.05% | -5.7% |
| Q4 2021 | $412,000 | +7.6% | 9,338 | -7.0% | 0.05% | 0.0% |
| Q3 2021 | $383,000 | -7.5% | 10,038 | -3.5% | 0.05% | -7.0% |
| Q2 2021 | $414,000 | +10.1% | 10,400 | -1.2% | 0.06% | +5.6% |
| Q1 2021 | $376,000 | -17.9% | 10,530 | -15.5% | 0.05% | -22.9% |
| Q4 2020 | $458,000 | -2.6% | 12,463 | 0.0% | 0.07% | -10.3% |
| Q3 2020 | $470,000 | -8.9% | 12,463 | -1.4% | 0.08% | -15.2% |
| Q2 2020 | $516,000 | +7.9% | 12,638 | 0.0% | 0.09% | -6.1% |
| Q1 2020 | $478,000 | -25.4% | 12,638 | -7.3% | 0.10% | -3.0% |
| Q4 2019 | $641,000 | +10.1% | 13,638 | 0.0% | 0.10% | -1.0% |
| Q3 2019 | $582,000 | -3.0% | 13,638 | -9.0% | 0.10% | -4.7% |
| Q2 2019 | $600,000 | -4.9% | 14,991 | -0.7% | 0.11% | -7.0% |
| Q1 2019 | $631,000 | +2.6% | 15,091 | -6.2% | 0.12% | +16.2% |
| Q4 2018 | $615,000 | -14.3% | 16,091 | -10.0% | 0.10% | -14.7% |
| Q3 2018 | $718,000 | -2.3% | 17,883 | -2.0% | 0.12% | -12.1% |
| Q2 2018 | $735,000 | +1.1% | 18,243 | -1.9% | 0.13% | +10.9% |
| Q1 2018 | $727,000 | -0.7% | 18,605 | -9.9% | 0.12% | +3.5% |
| Q4 2017 | $732,000 | -14.8% | 20,651 | -2.4% | 0.12% | -16.1% |
| Q3 2017 | $859,000 | -10.7% | 21,153 | -5.2% | 0.14% | -12.7% |
| Q2 2017 | $962,000 | -6.3% | 22,305 | -8.5% | 0.16% | -7.6% |
| Q1 2017 | $1,027,000 | +2.3% | 24,373 | -6.5% | 0.17% | -1.7% |
| Q4 2016 | $1,004,000 | -13.7% | 26,063 | -3.5% | 0.17% | -14.8% |
| Q3 2016 | $1,164,000 | +5.8% | 26,996 | +6.4% | 0.20% | +5.7% |
| Q2 2016 | $1,100,000 | +12.8% | 25,372 | +5.6% | 0.19% | +12.3% |
| Q1 2016 | $975,000 | +1.6% | 24,028 | +1.0% | 0.17% | -0.6% |
| Q4 2015 | $960,000 | +3.2% | 23,797 | -1.6% | 0.17% | -1.1% |
| Q3 2015 | $930,000 | -33.5% | 24,192 | -28.0% | 0.17% | -23.7% |
| Q2 2015 | $1,399,000 | -10.9% | 33,588 | -1.3% | 0.23% | -8.8% |
| Q1 2015 | $1,570,000 | +3.8% | 34,027 | -3.9% | 0.25% | +5.5% |
| Q4 2014 | $1,513,000 | -5.6% | 35,412 | +1.6% | 0.24% | -7.8% |
| Q3 2014 | $1,602,000 | -13.7% | 34,842 | +0.4% | 0.26% | -8.9% |
| Q2 2014 | $1,856,000 | -1.6% | 34,698 | -1.7% | 0.28% | +2.9% |
| Q1 2014 | $1,886,000 | -0.9% | 35,307 | -1.0% | 0.27% | +0.4% |
| Q4 2013 | $1,904,000 | -3.1% | 35,668 | -8.9% | 0.27% | -6.8% |
| Q3 2013 | $1,965,000 | -4.8% | 39,166 | -5.2% | 0.29% | -5.5% |
| Q2 2013 | $2,064,000 | – | 41,311 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |